Cargando…
Opioid Therapy Pharmacogenomics for Noncancer Pain: Efficacy, Adverse Events, and Costs
Chronic non-cancer pain is a debilitating condition associated with high individual and societal costs. While opioid treatment for pain has been available for centuries, it is associated with high variability in outcome, and a considerable proportion of patients is unable to attain relief from sympt...
Autores principales: | Xu, Yan, Johnson, Ana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791560/ https://www.ncbi.nlm.nih.gov/pubmed/24167729 http://dx.doi.org/10.1155/2013/943014 |
Ejemplares similares
-
Opioid Pharmacotherapy for Chronic Noncancer Pain: The American Experience
por: Chapman, C. Richard
Publicado: (2013) -
European clinical practice recommendations on opioids for chronic noncancer pain – Part 1: Role of opioids in the management of chronic noncancer pain
por: Häuser, Winfried, et al.
Publicado: (2021) -
Peripherally acting μ-opioid receptor antagonists as treatment options for constipation in noncancer pain patients on chronic opioid therapy
por: Pergolizzi, Joseph V, et al.
Publicado: (2017) -
Update on the role of naldemedine in opioid-induced constipation in patients with chronic noncancer pain
por: BouSaba, Joelle, et al.
Publicado: (2022) -
Health care resource use and cost differences by opioid therapy type among chronic noncancer pain patients
por: Landsman-Blumberg, Pamela B, et al.
Publicado: (2017)